Influenza, Human: all 2,265 studies
Page 14 of 23. Open to participants first (174), then studies with results posted, then the rest; newest registration first within each.
- A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Healthy AdultsCompletedNCT03357263Phase 1
- Study of Immune Responses to Influenza VaccinationCompletedNCT03346772Phase 4
- Safety, Tolerability, and Immunogenicity of VAL-339851 in Healthy Adult SubjectsCompletedNCT03345043Phase 1
- Immunogenicity and Safety of the Shenzhen Trivalent Inactivated Influenza Vaccine Versus a Trivalent Influenza Vaccine Comparator in Chinese Subjects 18 to 59 YearsCompletedNCT03344029Phase 4
- Cardiac Injury in Patients With InfluenzaStatus unknownNCT03339180
- Comparative Tests of Flu Vaccination Phone MessagesCompletedNCT03332992Not applicable
- Prevention of Influenza and Other Wintertime Respiratory Viruses Among Healthcare Professionals in IsraelCompletedNCT03331991
- Safety and Immunogencity of H7N9 Influenza Antigen With 2 Adjuvant Formulations in Healthy Adults in BrazilCompletedNCT03330899Phase 1
- Immunogenicity of Alternative Annual Influenza Vaccination Strategies in Older Adults in Hong KongCompletedNCT03330132Phase 4
- Early Flu Shots in SOTWithdrawnNCT03327987
- Flu Vaccine Responses in the Setting of Melanoma TreatmentActive, not recruitingNCT03315975Phase 4
- Effects of Aging on Primary and Secondary Vaccine ResponsesCompletedNCT03312699Phase 1
- Evaluation of the School Kids Influenza Prevention ProjectCompletedNCT03307642Not applicable
- Improved Novel VaccIne CombinaTion InflUenza StudyTerminatedNCT03300362Phase 2
- Centralized Reminder Recall - Flu RCT2CompletedNCT03294473Not applicable
- Study of the Safety, Tolerability and Immunogenicity of an Intranasal Influenza Vaccine Administered to Healthy AdultsCompletedNCT03293732Phase 1
- A Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Infants From 6 Months to 35 Months of AgeStatus unknownNCT03285997Phase 3
- The Immune Response to Influenza Vaccinations in Elderly IndividualsCompletedNCT03266237Phase 4
- Centralized IIS-based Reminder/Recall to Increase Childhood Influenza Vaccination Rates_2nd Trial in ColoradoCompletedNCT03246100Not applicable
- Promoting Influenza Vaccination In General Practice Waiting RoomsCompletedNCT03239795Not applicable
- Flufenamic Acid for Hospitalised Influenza InfectionStatus unknownNCT03238612Phase 2
- Biomarkers for the Prognosis of Influenza in ChildrenCompletedNCT03231995Not applicable
- Efficiency of Antagonist Drugs of the Cellular Transcriptomic Signature of Influenza A Virus Infection.TerminatedNCT03212716Phase 2
- Biomarkers Predicting Infectivity in an Experimental Human Influenza ModelStatus unknownNCT03207152Phase 1
- Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Patients 13-17 y.o.CompletedNCT03206346Phase 3
- Preliminary Study on Safety and Immunogenicity of Influenza A (H7N9) Vaccine in the PopulationCompletedNCT03196661Phase 1
- NK Cell Mediated Influenza Immunity During PregnancyTerminatedNCT03196245
- Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Children 7-12 y.o.CompletedNCT03191097Phase 3
- Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral InfectionsCompletedNCT03189537Phase 3
- Effects of Lactobacillus Coryniformis CECT5711 on Immune Response to Influenza Vaccination in Adults Over 65.CompletedNCT03167593Phase 2
- Study of Biomarkers of Immune Activation Associated with Symptoms and Immune Responses After Influenza Vaccination in AdultsCompletedNCT03160118Phase 4
- Efficacy and Safety Study of Ingavirin® 90 mg Once Daily to Treat Influenza and Other Acute Viral Infections in AdultsCompletedNCT03154515Phase 4
- Comparison of Routine IM Influenza Immunization and Administration by Jet-injector (Med-Jet H4™) in Healthy Young AdultsCompletedNCT03150537Phase 4
- High Dose vs. Standard Influenza Vaccine in Adult SOTCompletedNCT03139565Phase 3
- School-located Influenza Vaccination Clinics for AdolescentsCompletedNCT03137667Not applicable
- Pharmacodynamic Open-Label Trial With VXA-A1.1 Oral H1 Vaccine in Healthy AdultsCompletedNCT03121339Phase 1
- Assessment of Viral Shedding in Children Previously in Receipt of Multiple Doses of Live Attenuated Influenza Vaccine (LAIV) Compared to Influenza Vaccine-naïve ControlsCompletedNCT03104790Phase 4
- Genetic and Environmental Factors in the Response to Influenza VaccinationCompletedNCT03088904Phase 1
- Safety, Tolerability, and Immunogenicity of VAL-506440 in Healthy Adult SubjectsCompletedNCT03076385Phase 1
- Safety and Efficacy of Concurrent Administration of Influenza Vaccine in Patients Undergoing Anti-PD-1 Immunotherapy (Nivolumab, Pembrolizumab)CompletedNCT03061955
- Active Surveillance for Adverse Events Following Immunization With the Influenza Vaccine Produced at Butantan InstituteCompletedNCT03057483
- Recombinant H7 Hemagglutinin Influenza Vaccine TrialCompletedNCT03038776Phase 1
- Clinical Performance of the Diassess Influenza A and B TestCompletedNCT03035396Not applicable
- Dose Ranging Study to Evaluate the Efficacy and Safety of MEDI8852 in Adults Who Are Hospitalized With Type A Influenza.WithdrawnNCT03028909Phase 2
- Reactogenicity, Safety and Immunogenicity Study of a Allantoic Split Inactivated Seasonal Influenza VaccineCompletedNCT03028116Phase 1
- Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children Aged 6~35 MonthsCompletedNCT03020628Phase 3
- Immunogenicity and Safety Study of Allantoic Split Inactivated Seasonal Influenza Vaccine (VSI)CompletedNCT03016143Phase 2
- H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults: ImmunologyCompletedNCT03014310Phase 1
- Platelet Immune Responses in Aging and Influenza and Sepsis (INVACS)Status unknownNCT03010410
- Prospective Analysis of Seasonal Influenza - Viral Transmission and Evolution in the City of Basel, SwitzerlandCompletedNCT03010007
- Realization of the Recommendation for Influenza Vaccination in Pregnant WomenCompletedNCT03007797
- Protection From Influenza: Determining the Impact of Prior InfectionCompletedNCT03004040
- Trial of Perioperative Tadalafil and Influenza Vaccination in Cancer Patients Undergoing Major Surgical Resection of a Primary Abdominal MalignancyCompletedNCT02998736Phase 1
- Assessment of the Clinical Performance of the ARROW-FLU SystemStatus unknownNCT02996136Not applicable
- Comparison of Laser Assisted Epidermal to Intradermal Administration of Seasonal Influenza VaccineCompletedNCT02988739Phase 1
- Specific Respiratory Infections as Triggers of Acute Medical EventsCompletedNCT02984280
- Treatment of Influenza in Routine Clinical PracticeCompletedNCT02983019
- Impact of Rapid Flu Testing in BMC EDCompletedNCT02979730Not applicable
- A Study of Intranasal Live Attenuated Influenza Vaccine Immunogenicity and Associations With the Nasopharyngeal Microbiome Among Children in the GambiaCompletedNCT02972957Phase 4
- Rapid Assessment of and Prophylaxis for Influenza in Dwellers of Long-term Care FacilitiesCompletedNCT02964871Not applicable
- A Trial on the Efficacy, Safety and Immunogenicity of Live-Attenuated Influenza Vaccine (LAIV)CompletedNCT02964065Phase 3
- Imiquimod and Influenza Vaccine for Immunocompromised PatientsCompletedNCT02960815Phase 2
- Immunogenicity of Twice-annual Influenza Vaccination in Older Adults in Hong KongActive, not recruitingNCT02957890Phase 4
- Safety and Immunogenicity of Priming With Live Attenuated A/H7N9 Influenza Virus Vaccine Followed By Inactivated A/H7N9 Influenza Virus Vaccine With AS03 AdjuvantCompletedNCT02957656Phase 1
- Evaluation of the Safety and Immunogenicity of a Sublingual Influenza Vaccine NSV0001 in Healthy Male VolunteersCompletedNCT02955030Phase 1
- Safety and Effectiveness of a Seasonal Live Attenuated Influenza Vaccine in a Human Challenge Model of Infection With Wild-type (wt) Influenza A/California/2009 (H1N1)-Like VirusWithdrawnNCT02950688Phase 1
- Immunogenicity of Influenza Vaccine in Long Term CareStatus unknownNCT02933723Not applicable
- Centralized IIS-based Reminder/Recall to Increase Childhood Influenza Vaccination Rates in New York StateCompletedNCT02924467Not applicable
- Childhood Influenza Immunisation in General Practice Invitation TrialCompletedNCT02921633Not applicable
- A Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Subjects Aged 65 Years and OlderCompletedNCT02917304Phase 3
- A Study to Evaluate Efficacy and Safety of GC3110B in Healthy AdultsStatus unknownNCT02915809Phase 3
- Factors Associated With Parental Observation of Side Effects Following the Child Flu VaccineCompletedNCT02909855
- Effect of Drinking Fermented Milk on Immune ResponseCompletedNCT02909842Not applicable
- Influenza Vaccine Randomized Educational Trial: AdultCompletedNCT02907645Not applicable
- Influenza Vaccine Attitudes, Intent, and Receipt: PediatricCompletedNCT02907580Not applicable
- Influenza Vaccination and COPD PhenotypesCompletedNCT02900209
- 2-week dc of MTX and Influenza Vaccination in RAStatus unknownNCT02897011Not applicable
- A Drug-Drug Interaction Study to Evaluate the Effect of AL-794 on the Pharmacokinetics of Oseltamivir and JNJ-63623872CompletedNCT02888327Phase 1
- Childhood Influenza Immunisation Invitation Trial in SchoolsWithdrawnNCT02883972Not applicable
- Evaluating the Safety and Immunogenicity of a Live Attenuated Virus Vaccine to Prevent Influenza H3N2v DiseaseTerminatedNCT02883426Phase 1
- Adjuvanted Influenza Vaccination in U.S. Nursing HomesCompletedNCT02882100Phase 4
- Adjuvanted Inactivated Vaccine Versus Inactivated Influenza Vaccine in Hutterite ChildrenCompletedNCT02871206Phase 4
- Asymptomatic Flu ProjectCompletedNCT02868658Not applicable
- A Clinical Trial of KT07 Capsule in the U.S.ACompletedNCT02867358Phase 2
- Evaluation of the Alere i Influenza A&B Nucleic Acid Amplification Versus Xpert Flu/RSVCompletedNCT02846311
- Immunogenicity, Safety, and Tolerability of a Plant-Derived Quadrivalent VLP Influenza Vaccine in Elderly AdultsCompletedNCT02831751Phase 2
- Study on the Effect of Influenza Vaccination After Heart Attack on Future Cardiovascular PrognosisCompletedNCT02831608Phase 4
- Study to Evaluate Safety and Immunogenicity of Butantan Seasonal Influenza Vaccine - FLU-02-IBCompletedNCT02819180
- Cohort Study to Evaluate Safety and Immunogenicity of Butantan Seasonal Influenza VaccineCompletedNCT02819115
- Safety and Immunogenicity Study of Quadrivalent Influenza Virus Vaccine in Healthy People Aged Years 3-60Status unknownNCT02806804Phase 3
- Idylla IFV-RSV Panel Clinical TestingCompletedNCT02786381
- Immunogenicity of a Quadrivalent Virus-Like Particles (VLP) Influenza Vaccine in Healthy AdultsCompletedNCT02768805Phase 2
- Validation of the Ellume® Respirio Flu Test and the Ellume® eLab Flu Test for the Rapid Identification of Influenza A/BCompletedNCT02767414Not applicable
- Influenza Vaccine To Prevent Adverse Vascular Events (RCT-IVVE)Status unknownNCT02762851Phase 4
- Centralized IIS-based Reminder/Recall to Increase Childhood Influenza Vaccination RatesCompletedNCT02761551Not applicable
- Promotion of Influenza Vaccination in Healthcare Workers During the Recruitment VisitCompletedNCT02758145Not applicable
- Influenza Challenge Study in Healthy VolunteersCompletedNCT02746211Phase 1/2
- A Retrospective, Observational Registry of Participants With Avian Influenza InfectionCompletedNCT02743676
- Impact of Patient Education on Influenza Vaccine Uptake Among Community-dwelling Chinese ElderlyCompletedNCT02741843Not applicable
- Evaluate Safety of GCFLU® Administered Intramuscularly in Healthy Vietnamese Volunteer Aged From 3 Years OldCompletedNCT02723812Phase 4